Prohibits pre-approval or precertification of cancer treatments, tests, procedures, and prescription drugs.
New Jersey S2374 aims to eliminate the requirement for pre-approval or precertification of cancer treatments, tests, procedures, and prescription drugs under health benefits or prescription drug benefits plans. This bill ensures that insurance companies, third-party administrators, pharmacy benefits managers, and the State Health Benefits Program and the School Employees’ Health Benefits Program cannot impose pre-approval or precertification for cancer-related treatments, tests, procedures, or prescription drugs.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.